PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma-Reference-Cited by-同舟云学术

PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma

Published:2022-06-10 Issue:27 Volume:41 Page:3570-3583
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Liu Yating,Ouyang Lianlian,Mao Chao,Chen Yuanbing,Li Tiansheng,Liu Na^ORCID,Wang Zuli,Lai Weiwei,Zhou Yanling,Cao Ya^ORCID,Liu Shuang^ORCID,Liang Yinming^ORCID,Wang Min,Liu Shouping,Chen Ling,Shi Ying^ORCID,Xiao Desheng^ORCID,Tao Yongguang^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/s41388-022-02370-2.pdf

Reference34 articles.

1. Mazzaferro V, Citterio D, Bhoori S, Bongini M, Miceli R, De Carlis L, et al. Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial. Lancet Oncol. 2020;21:947–56.

2. Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015. JAMA Oncol. 2017;3:1683–91.

3. Li S, Liu R, Pan Q, Wang G, Cheng D, Yang J, et al. De novo lipogenesis is elicited dramatically in human hepatocellular carcinoma especially in hepatitis C virus-induced hepatocellular carcinoma. MedComm. 2020;1:178–87.

4. Fujiwara N, Friedman SL, Goossens N, Hoshida Y. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. J Hepatol. 2018;68:526–49.

5. Zhou X, Updegraff BL, Guo Y, Peyton M, Girard L, Larsen JE, et al. PROTOCADHERIN 7 acts through SET and PP2A to potentiate MAPK signaling by EGFR and KRAS during lung tumorigenesis. Cancer Res. 2017;77:187–97.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy;Frontiers in Immunology;2024-09-09

2. The Role of Ubiquitination in Regulating Ferroptosis;PROG BIOCHEM BIOPHYS;2024

3. EP300 through upregulating the expression of vimentin to promote the progression of chordoma;Neurosurgical Focus;2024-05

4. Epigenetic regulation of targeted ferroptosis: a new strategy for drug development;Journal of Pharmaceutical Analysis;2024-05

5. PPP2R1A silencing suppresses LUAD progression by sensitizing cells to nelfinavir-induced apoptosis and pyroptosis;Cancer Cell International;2024-04-23